12:00 AM
 | 
Feb 15, 2010
 |  BC Week In Review  |  Company News  |  Deals

Adagio Pharmaceuticals, Cannasat deal

The companies signed a letter of intent granting Cannasat an exclusive option to obtain exclusive, worldwide rights to develop and commercialize Adagio's APL-130277 to...

Read the full 106 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >